Biopharma stocks to see increased M&A activity amid Eli Lilly-Ventyx deal
Source: SeekingAlpha
2026-01-08 13:15:11 ET
More on biotech, biopharma
- Biotech: Time For A Pause To Start 2026
- 2026 Market Outlook: S&P 500 Looks Expensive, But Biotech Could Outperform Under The Hood
- iShares Biotechnology ETF: The M&A Wave Behind The Suddenly Booming Biotech Sector
- Short bets on S&P 500 Healthcare sector rises to 2.12% in November; MRNA stays most shorted stock
- SA Quant ranks Goldman's top 20 ETFs with the largest hedge fund ownership
Read the full article on Seeking Alpha
For further details see:
Biopharma stocks to see increased M&A activity amid Eli Lilly-Ventyx deal
VanEck Vectors Biotech ETF
NASDAQ: BBH
BBH Trading
0.05% G/L:
$182.52 Last:
3,961 Volume:
$182.09 Open:
